Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Orbis Medicines
We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Sign up for our quarterly newsletter to keep up with our…
Orbis Medicines
We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Sign up for our quarterly newsletter to keep up with our…
TL;DR
Founded / Launch: February 29, 2024
Headquarters: Copenhagen and Lausanne
Technology: AI-enabled nGen platform for orally dosable macrocycles
Total reported funding: €116M (seed + Series A)
Employee count (reported): 45
Company Overview
Problem Domain
Drug discovery and development for oral macrocycle therapeutics; replacing injectable biologics.
Founded
2024
Industry
Biotechnology / Biopharmaceuticals
Tech Stack
Funding Track Record
€26M
Company launch announcement accompanied seed financing
€90M
Series A brought total reported funding to €116M; other participants included Forbion, Novo Holdings, Lilly Ventures, Cormorant, and the Export and Investment Fund of Denmark
Investor Signal
“Investors include venture funds and corporate VC (Novo Holdings, Forbion, NEA, Lilly Ventures) and institutional/co-investors (Cormorant, Export and Investment Fund of Denmark)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |